Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Pfizer's Ibrance for advanced male breast cancer

pharmafileApril 11, 2019

Tag: FDA , Pfizer , Ibrance , male , Breast Cancer

PharmaSources Customer Service